Baryton Pharma Private Limited

Baryton Pharma Private Limited - pharma in Kozhikode, Kerala, India. FY 2026 financials & compliance.
CIN U24232KL2010PTC026716 Incorporated 17 September 2010 ROC Ernakulam HQ Kozhikode, Kerala, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹13.67 Cr
▲ 9% YoY
Net profit · FY 2025
₹88.16 Lakh
Net margin 6.5%
EBITDA · FY 2025
₹1.41 Cr
EBITDA margin 10.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹2.62 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings

About Baryton Pharma Private Limited

Data last updated:

Baryton Pharma Private Limited is a private limited company based in Kozhikode, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 September 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2010PTC026716. Its GSTIN is 32AAECB2985Q1Z7 (Kerala). The company holds 4 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Chelakkara Vaidyanathan Sriram (Managing Director) and Ranjish Rayaroth.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No .18/1001 – D Puthiyapalam Road Tali (P.O), Kozhikode, Kerala, India – 673002.

As per the financials filed for FY 2025, the company reported a revenue of ₹13.67 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹88.16 Lakh (net margin 6.5%) and EBITDA of ₹1.41 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 19% over five years.

As per MCA filings, the company has open charges of ₹2.62 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website barytonpharma.in.

Company details

CIN U24232KL2010PTC026716
Registration Number 026716
Incorporation Date 17 September 2010
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Baryton Pharma Private Limited's registered office is in Kozhikode, Kerala. Its website is barytonpharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Door No .18/1001 – D Puthiyapalam Road Tali (P.O), Kozhikode, Kerala, India – 673002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Baryton Pharma Private Limited, buy the company report.

Comprehensive company report
Baryton Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Baryton Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Baryton Pharma Private Limited, buy the company report.

Financials of Baryton Pharma Private Limited

FY 2025 filings available

Baryton Pharma Private Limited reported revenue of ₹13.67 Cr (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹13.67 Cr ▲ 9%
Net profit · FY 2025
₹88.16 Lakh margin 6.5%
EBITDA · FY 2025
₹1.41 Cr margin 10.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 19%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 46%
5 years · compounded
▲ 29%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 9% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.41 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹88.16 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.3%
Net Profit Margin6.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Baryton Pharma Private Limited, buy the company report.

Board of directors of Baryton Pharma Private Limited

Baryton Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ranjish RayarothDirector06 Jan 201115 Years 9 MonthsCurrent
Praveen ViswakumarDirector06 Jan 201115 Years 9 MonthsCurrent
Chelakkara Vaidyanathan SriramManaging Director17 Sep 201016 Years 1 MonthsCurrent

Peer comparison

Baryton Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Devoir Lifesciences Private Limited₹13.7 Cr (FY 2025)41.0%Ludhiana, Punjab, India
Plenum Biotech Private Limited₹13.69 Cr (FY 2024)50.0%Chandigarh, India
Baryton Pharma Private Limitedthis company₹13.67 Cr (FY 2025)₹88.16 Lakh6.5%9.0%Kozhikode, Kerala, India
Swaradhya Healthcare Private Limited₹13.65 Cr (FY 2025)-8.0%Lajpat Nagar, Uttar Pradesh, India

To see the full peer comparison of Baryton Pharma Private Limited, buy the company report.

Auditor

Baryton Pharma Private Limited is audited by Nathan & Comapany for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Nathan & ComapanyFY 2023002429S

Shareholding

The shareholding of Baryton Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Baryton Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2.62 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹1.42 Cr
Others₹1.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Aug 2025101170297Hdfc Bank Limited₹42.49 LakhOpen
30 Jul 2025101170271Hdfc Bank Limited₹41 LakhOpen
06 Jan 2025101032760Others₹1.2 CrOpen
02 Mar 2024100912072Hdfc Bank Limited₹52.77 LakhOpen
04 Feb 2022100555939Hdfc Bank Limited₹6 LakhOpen

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Baryton Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Baryton Pharma has 4 GST registrations: 4 active.

Total GSTINs
4
Active
4
GSTINStateStatusRegistered on
32AAECB2985Q1Z7KeralaActive01 Jul 2017
32AAFCB6578A1ZYKeralaActive01 Jul 2017
33AAFCB6578A1ZWTamil NaduActive28 Sep 2019
21AAFCB6578A1Z1OdishaActive30 Aug 2022

To see the full GST registrations and return filing status of Baryton Pharma Private Limited, buy the company report.

Recent activity

Baryton Pharma Private Limited has 7 board changes on record since 2010: 3 appointments and 4 cessations. The latest: Shiju Chembra ceased to be Director on 23 Apr 2021.

AGM
Baryton Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 42.49 Lakh with Charge ID 101170297 was registered on 04 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 41.00 Lakh with Charge ID 101170271 was registered on 30 Jul 2025.
Filing
Baryton Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Others amounted to Rs. 120.00 Lakh with Charge ID 101032760 was registered on 06 Jan 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 52.77 Lakh with Charge ID 100912072 was registered on 02 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.00 Lakh with Charge ID 100555939 was registered on 04 Feb 2022.
Ceased
Shiju Chembra ceased to be Director.
Ceased
Lakshmy Chelakara Krishna Iyer ceased to be Director.
Ceased
Peeja Rajan ceased to be Director.
Appointed
Praveen Viswakumar was appointed as Director.
Appointed
Ranjish Rayaroth was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Baryton Pharma is an active private limited company based in Kozhikode, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 September 2010 (16+ years old) and is registered under CIN U24232KL2010PTC026716.

Baryton Pharma has 3 current directors:

The latest financial statements of Baryton Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Baryton Pharma is 32AAECB2985Q1Z7, registered in Kerala. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 32AAFCB6578A1ZY (Kerala), 33AAFCB6578A1ZW (Tamil Nadu), 21AAFCB6578A1Z1 (Odisha).

The CIN (Corporate Identification Number) of Baryton Pharma is U24232KL2010PTC026716. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Baryton Pharma was incorporated on 17 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ernakulam.

The peers of Baryton Pharma by revenue are Devoir Lifesciences Private Limited, Plenum Biotech Private Limited, Swaradhya Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Shiju Chembra ceased to be Director on 23 Apr 2021. Lakshmy Chelakara Krishna Iyer ceased to be Director on 06 Jan 2011. Peeja Rajan ceased to be Director on 06 Jan 2011. Baryton Pharma has 7 board changes on record in total.

Baryton Pharma can be reached through the website barytonpharma.in. Its registered office is in Kozhikode, Kerala, India.

The registered office of Baryton Pharma is at Door No .181001 – D Puthiyapalam Road Tali P.O, Kozhikode, Kerala, India – 673002.

Baryton Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.